OmeprazoleImmune-mediated drug-induced liver injury: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1831卷 / 1期

关键词：

D O I：

10.1007/s40278-020-86493-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：237 / 237

相关论文

共 50 条

[1] OlaparibImmune mediated drug-induced liver injury: case report
Reactions Weekly, 2021, 1836 (1) : 612 - 612
[2] Mosapride/rabeprazoleImmune-mediated drug-induced liver injury: case report
Reactions Weekly, 2019, 1746 (1) : 133 - 133
[3] PomalidomideFirst report of drug-induced liver injury: case report
Reactions Weekly, 2014, 1510 (1) : 35 - 35
[4] LevocetirizineFirst report of drug-induced liver injury: case report
Reactions Weekly, 2017, 1642 (1) : 180 - 180
[5] TerbinafineCholestatic drug-induced liver injury: case report
Reactions Weekly, 2023, 1960 (1) : 402 - 402
[6] CanagliflozinFirst report of drug-induced liver injury: case report
Reactions Weekly, 2015, 1539 (1) : 75 - 75
[7] AlemtuzumabHepatitis and drug-induced liver injury: case report
Reactions Weekly, 2019, 1738 (1) : 15 - 15
[8] DoxazosinAsthenia and drug-induced liver injury: case report
Reactions Weekly, 2021, 1873 (1) : 106 - 106
[9] ClotrimazoleAcute drug-induced liver injury: case report
Reactions Weekly, 2022, 1896 (1) : 136 - 136
[10] DaptomycinRhabdomyolysis and drug-induced liver injury: case report
Reactions Weekly, 2016, 1605 (1) : 68 - 68

← 1 2 3 4 5 →